Alpha DNA Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-147,651
| Closed | -$703K | – | 182 |
|
|
2023
Q2 | $703K | Buy |
+147,651
| New | +$703K | 0.23% | 132 |
|
|
2023
Q1 | – | Sell |
-102,094
| Closed | -$1.03M | – | 161 |
|
|
2022
Q4 | $1.03M | Buy |
+102,094
| New | +$1.03M | 0.36% | 116 |
|
|
2021
Q2 | – | Sell |
-63
| Closed | -$4K | – | 286 |
|
|
2021
Q1 | $4K | Buy |
63
+16
| +34% | +$1.02K | ﹤0.01% | 406 |
|
|
2020
Q4 | $4K | Buy |
+47
| New | +$4K | ﹤0.01% | 392 |
|